. CD4+ T cell in solid-organ recipients with and without CMV infection.
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No reported disclosures. Background. Cytomegalovirus (CMV) infection causes significant morbidity after transplant. Patients can be stratified by donor and recipient CMV serostatus, but the infection phenotype remains variable. We hypothesized that some of this variability might be explained by circadian rhythms influenced by time of transplant.
Is Primary CMV Infection Post-transplant Influenced by Circadian
Methods. Virological, demographic and transplant data were reviewed for liver and kidney transplant patients (n = 1,111) managed between 2002 and 2015 using pre-emptive therapy. Donor circulatory arrest time and reperfusion time in the recipient were split into four categories, chosen a priori. Patients were categorised into three groups depending on donor and recipient CMV serostatus. Differences between groups were assessed using chi-squared and Kruskall-Wallis tests.
Results. For the donor seropositive/recipient seronegative group (D+R−) all CMV parameters were highest when reperfusion occurred in the day or evening, and the lowest in the night or morning (see table) . Conclusion. Time of day of transplant surgery appears to be associated with development of CMV viraemia and the parameters of infection in one subgroup of transplant patients. These differences could be explained by circadian rhythms of CMV replication and/or immunological parameters varying throughout the day. These data therefore provide support for further study of circadian effects on CMV replication and host CMV immunity.
Disclosures. P. Griffiths, shire: Scientific Advisor, funds paid to my institution not to me; chimerix: Scientific Advisor, funds paid to my institution not to me; sanofi pasteur: Grant Investigator, funds paid to my institution not to me; genentech: Scientific Advisor, funds paid to my institution not to me. Background. Recent sepsis definitions for the general population include Sequential Organ Failure Assessment (SOFA) ≥ 2 for patients admitted to intensive care unit (ICU), and quick SOFA (qSOFA) ≥ 2 for non-ICU patients. The objective of this study was to validate the predictive value of SOFA and qSOFA in immunocompromised patients.
Predicting Mortality Among Immunocompromised Patients Who Present with Infection
Methods. Adult patients admitted between 2014 and 2017 with ICD-9 and ICD-10 codes for hematologic malignancies or transplant diagnoses who had suspected infection were included. Index date of suspected infection was defined as the time when blood culture was obtained, followed by intravenous antibiotic therapy, or vice versa (based on the definition used in SEPSIS-3 study, Seymour et al.) . SOFA, qSOFA and SIRS components within 1 day of the index date were extracted from the medical record. A baseline risk model of mortality was created including age, race, gender, and Charlson comorbidity index. Each score was added to the baseline mortality risk model as a dichotomous variable (SOFA ≥ 2, qSOFA ≥ 2, and SIRS ≥ 2). For each risk model, a receiver operating characteristic (ROC) curve was developed and the area under ROC (AUROC) was calculated. Sensitivities of SOFA ≥ 2, qSOFA ≥ 2, and SIRS ≥ 2 for predicting in-hospital mortality were calculated.
Results. A total of 2,917 patients with a mean age of 57.0 ± 15.7 were included; 57% were male and 84% white. The most common immunocompromising conditions were solid-organ transplantation (45%), lymphoma (24%), acute leukemia (17%) and hematopoietic stem cell transplantation (6%). Two hundred and seventeen patients died during index admission (7.4%). The sensitivities of SOFA ≥ 2, qSOFA ≥ 2 and SIRS ≥ 2 for predicting in-hospital mortality were 94.9, 64.1 and 91.7%, respectively (P < 0.001 for each score ≥2 compared with <2). In the mortality risk model, the AUROCs for qSOFA, SOFA and SIRS were 0.75, 0.70 and 0.71, respectively (Figure) . The AUROC for qSOFA ≥2 was significantly higher than for SIRS ≥2 and SOFA ≥2 (P = 0.004, P < 0.001, respectively).
Conclusion. qSOFA ≥2 was the strongest predictor of mortality in immunocompromised patients and may aid in risk stratification and clinical decision-making. Additional analyses are needed to evaluate alternative and potentially improved scoring systems for sepsis in immunocompromised populations.
